市場調查報告書
商品編碼
1399615
馬醫療保健市場規模 - 按產品(疫苗、藥品、醫療添加劑、診斷)、適應症(寄生蟲控制、馬腦脊髓炎、馬流感)、配銷通路、全球預測,2023-2032 年Equine Healthcare Market Size - By Product (Vaccines, Pharmaceuticals, Medical Additives, Diagnostics), Indication (Parasite Control, Equine Encephalomyelitis, Equine Influenza), Distribution Channel, Global Forecast, 2023-2032 |
由於人們越來越重視馬匹的預防性醫療保健措施,預計 2023 年至 2032 年馬匹醫療保健市場規模將以 6.4% 的CAGR擴大。最近,馬主和獸醫越來越認知到主動健康管理的重要性,包括疫苗接種計劃、寄生蟲控制和例行檢查。預防措施不僅可以提高馬匹的整體健康狀況,還可以促進性能最佳化和壽命延長。向預防性保健方法的轉變也反映了對維持馬群健康和活力的承諾,推動了對預防性保健產品和服務的需求。
此外,一些產業參與者正在進行大量研發投資,推出新產品和服務,以滿足馬匹的不同健康需求,從而支持市場成長。例如,2023 年 4 月,Hilltop Bio 推出了創新的馬關節健康解決方案 Strydaflex,擴大了其室溫再生藥物的範圍。
馬保健品產業分為產品、適應症、配銷通路和地區。
從產品來看,由於全球馬領域對動物健康和福利的日益重視,疫苗領域的市場佔有率從 2023 年到 2032 年的CAGR可能為 7.2%。疫苗在預防和控制馬匹多種傳染病方面日益受到重視。此外,持續的研發工作有助於創造先進和專用的馬匹疫苗,以確保全面的保護,從而增加產品需求。
在配銷通路方面,電子商務領域的馬保健品市場在 2022 年錄得可觀的銷售額,預計 2023 年至 2032 年的CAGR為7%。線上平台可以方便地獲取各種馬保健品、補充劑、和藥物。此外,電子商務網站為馬主和獸醫專業人士提供了便利,使他們能夠在舒適的家中和診所瀏覽、比較和購買產品,從而促進該細分市場的成長。
從地區來看,在馬術文化日益普及以及該地區對高性能馬匹的需求不斷成長的推動下,亞太地區馬匹保健行業預計將在2023年至2032年間以7%的成長率強勁成長。政府和私營部門對馬設施開發的投資激增,提高了人們對馬健康的認知。此外,亞洲主要國家賽馬、運動、休閒等多元化馬術活動的普及將進一步加速區域市場的擴張。
Equine Healthcare Market size is anticipated to expand at 6.4% CAGR from 2023-2032 driven by the growing emphasis on preventive healthcare measures for horses. Of late, horse owners and veterinarians are increasingly recognizing the importance of proactive health management, including vaccination programs, parasite control, and routine check-ups. Preventive measures not only enhance the overall well-being of horses but also boost performance optimization and longevity. The shift towards preventive healthcare approaches also reflects a commitment to maintaining the health and vitality of equine populations, driving the demand for preventive care products and services.
Furthermore, several industry participants are making massive R&D investments to launch new products and services for catering to different health needs of horses, in turn, supporting the market growth. For instance, in April 2023, Hilltop Bio expanded its range of room-temperature regenerative medicines with the launch of Strydaflex, an innovative horse joint health solution.
The equine healthcare industry is segmented into product, indication, distribution channel, and region.
Based on product, the market share from the vaccines segment is likely to witness 7.2% CAGR from 2023-2032 attributed to the rising emphasis on animal health and welfare in the global equine domain. Vaccines are gaining prominence for preventing and controlling numerous infectious diseases among horses. Additionally, the ongoing R&D efforts are contributing to the creation of advanced and specialized equine vaccines for ensuring comprehensive protection, boosting the product demand.
In terms of distribution channel, the equine healthcare market from the e-commerce segment recorded substantial sales in 2022 and is estimated to depict 7% CAGR from 2023 to 2032. Online platforms facilitate easy access to a wide range of equine health products, supplements, and medications. Additionally, e-commerce sites offer convenience for enabling horse owners and veterinary professionals to browse, compare, and purchase products from the comfort of their homes and clinics, thereby contributing to the segment growth.
Regionally, the Asia Pacific equine healthcare industry is set to exhibit robust growth at a 7% growth rate between 2023 and 2032 propelled by the rising popularity of equestrian culture, and the growing demand for high-performance horses in the region. Surging government and private sector investments for the development of equine facilities has led to the higher awareness about horse health. Moreover, the popularity of diverse equine activities, including racing, sports, and leisure across the major Asian countries will further accelerate the regional market expansion.